Since the 1940s, Pap smears have been the primary screening method for cervical cancer. However, new guidelines have emerged from a draft recommendation by the U.S. Preventive Services Task Force (USPSTF). Instead, the panel of medical experts now recommends HPV testing as a primary screening option for cervical cancer.
Pap smears are conducted by collecting a sample of cells. During a pelvic exam, a medical practitioner uses a small instrument to collect cells from the cervix. The doctors then examine the sample for abnormal cells that could eventually become cancerous. But, while effective, pap smears don’t specifically identify the cause of most cervical cancers: the human papillomavirus (HPV). In fact, 99% of cervical cancer cases are linked to HPV.
HPV is a sexually transmitted infection that spreads through intimate skin-to-skin contact. HPV infections are common, with most people exposed at some point in their lives. However, persistent HPV infections are the key driver of cervical cancer, as they can trigger lasting changes to cervical cells that can develop into cancer. Given this direct connection between HPV and cancer risk, testing for the infection itself provides a crucial early warning system. HPV tests detect high-risk strains of the virus, even before cellular changes occur. Experts note that this type of testing is more sensitive than Pap smears at detecting precancerous conditions.
Based on this enhanced detection capability, the USPSTF now recommends that women aged 25 to 65 consider HPV testing as their primary screening method every five years. For those women who prefer it, Pap smears or co-testing (Pap and HPV testing together) remain acceptable options, providing flexibility in screening choices. For women under 25, the USPSTF still recommends Pap testing every 3 years.
HPV testing methods are evolving rapidly, with new options becoming more accessible. One of the most exciting developments in cervical cancer prevention is the rise of self-swab HPV testing. This method allows women to collect a sample at home, providing a more accessible and private alternative for those who face barriers to traditional screenings. While not yet a replacement for in-office screenings, studies suggest that self-swab tests could be critical in increasing screening rates, particularly among women in underserved communities.
SOURCES